Effects of tolcapone on working memory and brain activity in abstinent smokers: A proof-of-concept study

BACKGROUND: Dopamine levels in the prefrontal cortex (PFC) are thought to play an important role in cognitive function and nicotine dependence. The catechol-O-methyltransferase (COMT) inhibitor tolcapone, an FDA-approved treatment for Parkinson’s disease, increases prefrontal dopamine levels, with c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ashare, Rebecca L., Wileyto, E. Paul, Ruparel, Kosha, Goelz, Patricia M., Hopson, Ryan D., Valdez, Jeffrey N., Gur, Ruben C., Loughead, James, Lerman, Caryn
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3960598/
https://ncbi.nlm.nih.gov/pubmed/24095246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2013.09.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados